tno.nl
IBDigital Project Starts at ECCO Conference in Berlin
This project aims to develop wearable-based digital biomarkers to detect IBD flares earlier and make remote monitoring easier, which could help patients and clinicians manage disease more proactively. It describes planned studies and partnerships but does not report clinical results yet.
People living with IBD, patient advocates, clinicians involved in IBD care, digital health researchers, and industry partners working on wearables or biomarkers.
What To Know
What to know The IBDigital project launched at ECCO aims to develop wearable-driven digital biomarkers to detect IBD flares earlier and support remote monitoring.
Partners include academic centers, patient groups, medtech firms, and pharmaceutical companies; the project will run a three-year program with retrospective data work, co-design with patients, and a longitudinal wearable study.
The project emphasizes passive data (heart rate variability, sleep, activity) to reduce questionnaire burden and improve inclusivity. It plans to validate a clinically useful digital biomarker and create an adoption roadmap for wider clinical use.
Why this matters Digital biomarkers could make remote monitoring less burdensome, help spot flares sooner, and support more timely, data-driven care — which may reduce clinic visits and hospital admissions for people with IBD.
How to read this This announcement describes a new collaborative research program and plans for studies; it is not reporting final trial results or a ready-to-use clinical tool.
This is an announcement of a multi-year research and development program (public–private partnership). The article outlines planned retrospective analyses, co-design with patients, and a longitudinal wearable study — it does not present validated biomarker results or clinical recommendations yet.
